MBE Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,978
Closed -$530K 87
2023
Q1
$530K Sell
25,978
-5,542
-18% -$111K 0.31% 33
2022
Q4
$669K Buy
31,520
+2,127
+7% +$44.1K 0.43% 26
2022
Q3
$598K Buy
+29,393
New +$585K 0.44% 25

Other funds holding BTAL

MBE Wealth Management's BTAL Position: Q2 2023 in Review

MBE Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 25,978 shares — an estimated $530K sold.

MBE Wealth Management first reported a position in BTAL in Q3 2022 and held it in 3 quarters. The position peaked at $669K in Q4 2022. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • MBE Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • MBE Wealth Management sold 25,978 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $530K.
  • MBE Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 3 quarters.
  • MBE Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $669K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on MBE Wealth Management's 13F filing for Q2 2023, filed 17 Jul 2023.